Predicting impacts of mass-screening policy changes on breast cancer mortality

Statistics in Medicine

Volumn 27, Issue 25, 2008, Pages 5235-5251

  Seppänen, Johanna ^a   Heinävaara, Sirpa ^a,b   Hakulinen, Timo ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

Breast cancer; Cure model; Mass screening; Mortality; Prediction; Survival

Indexed keywords

ARTICLE; BREAST TUMOR; FINLAND; FORECASTING; HUMAN; MANAGEMENT; MASS SCREENING; MORTALITY; STATISTICAL MODEL; STATISTICS;

BREAST NEOPLASMS; FINLAND; FORECASTING; HUMANS; MASS SCREENING; MODELS, STATISTICAL; POLICY MAKING;

EID: 55849137354     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3345     Document Type: Article

References (21)

1. Hakama M, Piikkala E, Söderman B, Day N. Implemenlation of screening as a public health policy: issues in design and evaluation. Journal of Medical Screening 1999: 6:209-216.
2. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. Journal of Medical Screening 2002; 9:153-158.
3. Parvinen I. Helenius H, Pylkkäinen L, Anttila A, Immonen-Räihä P, Kauhava L, Räsänen O, Klemi PJ. Service screening mammography reduces breast cancer mortality among elderly women in Turku. Journal of Medical Screening 2006; 13:34-40.
4. Sarkeala T, Heinävaara S, Anttila A. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. International Journal of Cancer 2008; 122:614-619.
5. Seppänen J, Heinävaara S, Hakulinen T. Influence of alternative screening scenarios on breast cancer incidence predictions (Finland). Cancer Causes and Control 2006: 17:1135-1144.
6. Seppänen J, Heinävaara S. Anttila A, Sarkeala T, Virkkunen H, Hakulinen T. Effects of different phases of an invitational screening programme on breast cancer incidence. International Journal of Cancer 2006; 119:920-924.
7. Heinävaara S, Hakulinen T. Predicting the lung cancer burden: accounting for selection of the patients with respect to general population mortality. Statistics in Medicine 2006; 25:2967-2980.
8. De Angelis R, Capocaccia R, Hakulinen T, Söderman B, Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Statistics in Medicine 1999; 18:441-454.
9. Phillips N, Coldman A, McBride ML. Estimating cancer prevalence using mixture models for cancer survival. Statistics in Medicine 2002; 21:1257-1270.
10. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. European Journal of Cancer 2004: 40:2116-2125.
11. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Statistics in Medicine 1987; 6:449-467.
12. SAS Institute Inc. SAS/STA7® User's Guide, Version 8. SAS Institute Inc.: Cary, NC, 1999; 2371-2418.
13. Chatfield C. Time-series Forecasting. Chapman & Hall: Boca Raton, FL, 2001; 151-180.
14. Yu B, Tiwari RC, Cronin KA, Feuer EJ. Cure fraction estimation from the mixture cure models for grouped survival data. Statistics in Medicine 2004; 23:1733-1747.
15. Berkson J, Gage RP. Survival curves for cancer patients following treatment. Journal of American Statistical Association 1952: 47:501-515.
16. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Statistics in Medicine 2002; 21:3511-3526.
17. Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modelling the cure fraction in population-based cancer survival analysis. Biostatistics 2007 ; 8(3):576-594.
18. Brenner H, Hakulinen T. Are patients diagnosed with breast cancer before age 50 years ever cured? Journal of Clinical Oncology 2004; 22:432-438.
19. Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, Cirilli C, Ferretti S, Mangone L, Finarelli AC, Rosso S, Segnan N, Stracci F, Traina A, Tumino R, Zorzi M. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening in Italy. Breast Cancer Research 2006; 8:R68.
20. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine 2005; 353:1784-1792.
21. Hakulinen T, Dyba T. Precision of incidence predictions based on Poisson distributed observations. Statistics in Medicine 1994; 13:1513-1523.